Literature DB >> 32152145

Retinal cavitations in macular telangiectasia type 2 (MacTel): longitudinal structure-function correlations.

Cindy X Cai1, John Choong1, Sina Farsiu1, Stephanie J Chiu2, Emily Y Chew3, Glenn J Jaffe4.   

Abstract

BACKGROUND/AIMS: To quantify retinal cavitation size over time in macular telangiectasia type 2 (MacTel) and to correlate changes with visual acuity and area of ellipsoid zone loss.
METHODS: Optical coherence tomography (OCT) macula volume scans from sham eyes included in a prospective, phase II clinical trial of human ciliary neutrophic factor for MacTel at baseline, 1 year and 2 years of follow-up were analysed. Cavitations were segmented by two independent readers. Total cavitation volume was compared with area of ellipsoid zone loss and best-corrected visual acuity (BCVA).
RESULTS: Fifty-one eyes from 51 unique patients (mean age 62 years, range 45-79 years) were included. Intraclass correlation between readers for cavitation volume was excellent (>0.99). Average cavitation volume was 0.0109 mm3, 0.0113 mm3 and 0.0124 mm3 at baseline, 1 year and 2 years, respectively. The average rate of cavitation volume change was +0.0039 mm3/year. 10 eyes (20%) had a significant change in cavitation volume during the study (3 decreased, 7 increased). Eyes with increased cavitation volume had worse BCVA compared with eyes with no change/decreased cavitation volume (71.5 vs 76.1 ETDRS letters, respectively). Cavitation volume was negatively correlated to BCVA (r=-0.37) but not to area of ellipsoid zone loss. Cavitation volume was negatively predictive of BCVA in both univariate and multivariate mixed-effects modelling with ellipsoid zone loss.
CONCLUSIONS: Retinal cavitations and their rate of change in MacTel can be reliably quantified using OCT. Cavitations are negatively correlated with visual acuity and may be a useful OCT-based biomarker for disease progression and visual function in MacTel. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Macula; Retina

Mesh:

Year:  2020        PMID: 32152145      PMCID: PMC8841952          DOI: 10.1136/bjophthalmol-2019-315416

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  24 in total

1.  Progressive changes from idiopathic macular telangiectasia seen with spectral domain optical coherence tomography.

Authors:  Katherine A Fallano; Mohamed Ibrahim; Quan Dong Nguyen; Diana V Do
Journal:  Can J Ophthalmol       Date:  2010-12       Impact factor: 1.882

2.  Perifoveal müller cell depletion in a case of macular telangiectasia type 2.

Authors:  Michael B Powner; Mark C Gillies; Marina Tretiach; Andrew Scott; Robyn H Guymer; Gregory S Hageman; Marcus Fruttiger
Journal:  Ophthalmology       Date:  2010-08-03       Impact factor: 12.079

Review 3.  New functions of Müller cells.

Authors:  Andreas Reichenbach; Andreas Bringmann
Journal:  Glia       Date:  2013-02-26       Impact factor: 7.452

4.  Müller cells separate between wavelengths to improve day vision with minimal effect upon night vision.

Authors:  Amichai M Labin; Shadi K Safuri; Erez N Ribak; Ido Perlman
Journal:  Nat Commun       Date:  2014-07-08       Impact factor: 14.919

5.  CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Authors:  Ferenc B Sallo; Irene Leung; Traci E Clemons; Tunde Peto; Emily Y Chew; Daniel Pauleikhoff; Alan C Bird
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

6.  Idiopathic juxtafoveolar retinal telangiectasis.

Authors:  J D Gass; R T Oyakawa
Journal:  Arch Ophthalmol       Date:  1982-05

7.  Loss of Müller's cells and photoreceptors in macular telangiectasia type 2.

Authors:  Michael B Powner; Mark C Gillies; Meidong Zhu; Kristis Vevis; Alex P Hunyor; Marcus Fruttiger
Journal:  Ophthalmology       Date:  2013-06-12       Impact factor: 12.079

8.  Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.

Authors:  Emily Y Chew; Traci E Clemons; Glenn J Jaffe; Charles A Johnson; Sina Farsiu; Eleonora M Lad; Robyn Guymer; Philip Rosenfeld; Jean-Pierre Hubschman; Ian Constable; Henry Wiley; Lawrence J Singerman; Mark Gillies; Grant Comer; Barbara Blodi; Dean Eliott; Jiong Yan; Alan Bird; Martin Friedlander
Journal:  Ophthalmology       Date:  2018-10-04       Impact factor: 12.079

9.  Estimating Retinal Sensitivity Using Optical Coherence Tomography With Deep-Learning Algorithms in Macular Telangiectasia Type 2.

Authors:  Yuka Kihara; Tjebo F C Heeren; Cecilia S Lee; Yue Wu; Sa Xiao; Simone Tzaridis; Frank G Holz; Peter Charbel Issa; Catherine A Egan; Aaron Y Lee
Journal:  JAMA Netw Open       Date:  2019-02-01

10.  Deep longitudinal transfer learning-based automatic segmentation of photoreceptor ellipsoid zone defects on optical coherence tomography images of macular telangiectasia type 2.

Authors:  Jessica Loo; Leyuan Fang; David Cunefare; Glenn J Jaffe; Sina Farsiu
Journal:  Biomed Opt Express       Date:  2018-05-16       Impact factor: 3.732

View more
  5 in total

1.  Visual acuity after cataract surgery in Macular Telangiectasia Type 2 Stage 3 to 5.

Authors:  Jacob S Heng; J Fernando Arevalo; James T Handa
Journal:  Int J Retina Vitreous       Date:  2022-06-11

2.  Deep learning-based classification and segmentation of retinal cavitations on optical coherence tomography images of macular telangiectasia type 2.

Authors:  Jessica Loo; Cindy X Cai; John Choong; Emily Y Chew; Martin Friedlander; Glenn J Jaffe; Sina Farsiu
Journal:  Br J Ophthalmol       Date:  2020-11-23       Impact factor: 4.638

3.  Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiectasia.

Authors:  Tyler A Berger; Matthew W Manry; Lucas B Lindsell; James M Osher; Daniel M Miller; Robert E Foster; Christopher D Riemann; Michael R Petersen; Robert A Sisk
Journal:  Clin Ophthalmol       Date:  2021-03-15

4.  Commentary: Imaging in macular telangiectasia type 2 - Correlating structural change with vision.

Authors:  Muna Bhende
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

5.  Structural-vascular-functional correlation in type 2 non-proliferative macular telangiectasia.

Authors:  Ramesh Venkatesh; Nikitha Gurram Reddy; Pranjal Mishra; Naresh Kumar Yadav; Jay Chhablani
Journal:  Int J Retina Vitreous       Date:  2022-08-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.